STRENGTHENING PROVIDER PATIENT COMMUNICATION SKILLS IN CLINICAL TRIALS
About ENACCT
A non-profit organization founded in 2004
Our Mission: To improve access to cancer clinical trials through education and collaboration with communities, health care providers, and researchers
We seek to increase cancer clinical trial participation and access to quality care for all cancer patients—especially from underserved communities
Agenda
Accrual: Our perspective Consent- we know about that… Consent-A greater focus on comprehension
Literacy and Language Cultural Competency: Creating a Patient Centered
Consent Process
Trying on some new ways to explain old concepts
3
ENACCTs Perspective on the “accrual problem”4
What Will it Take to Accrual?
While numerous challenges face clinical research, often overlooked are challenges related to ineffective and/or inefficient operational procedures community relationships Physician/research staff communication
with patients
National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. 2010. Institute of Medicine of the National Academies; Ford, J.G., et al. (2005). Evidence Report: Technology Assessment (Summary), (122) 1-11; Wendler D., PLoS Med, Feb;3(2):e19. Epub 2005; Ulrich CM, James JL, et al Contemp Clin Trials. 2010 May;31(3):221-8; Comis RL, et al. J Oncol Pract. 2009;5(2):50-6
5
© 2013 ENACCT Inc. All Rights Reserved
Increasing Accrual is Based on a Conversation Between Providers & Patients, But…
1. How can we get more of these conversations to take place?
2. How can we ensure quality patient-provider communication around
consent, especially for ethnic and racial minority groups?
1 eligible and interested patient
Pt 3
Pt 1Pt 2
6
© 2013 ENACCT Inc. All Rights Reserved
Addressing Quality of Care
“Therapies offered through CCTs should ideally be considered the preferred treatment choice for physicians and patients, if they are available” NCCN, 2008
Physicians should “strive to make participation in clinical trials a key component of clinical practice and to achieve…high accrual rates of 10% or more. (Institute of Medicine, 2010)
COC 2015 Accreditation Guidelines
Participation in Cancer Research as Quality Care
7
© 2013 ENACCT Inc. All Rights Reserved
3% vs. 20%: What’s Going On?
Low rates of participation 3% of all adults when approximately 20% are eligibleEven fewer minority, elderly and rural
populations CCTs are quality cancer care but often considered
apart from standard treatment
So how many patients are we missing?
8
Christian, M. C., & Trimble, E. L. (2003).. Cancer EpidemW iology Biomarkers & Prevention. 12: 277s-283s. Cancer clinical trials: A resource guide for outreach, education, and advocacy. (2006). Retrieved from the NCI web site ; Digest Page: Boosting Cancer Trial Participation. (2008). Retrieved from the NCI web site ; Brawley, O. (2004). Journal of Clinical Oncology. 22(11): 2039-2040. Murthy, V,H. et al (2004). JAMA. 291(22):2720-6.; Stewart et al. (2007). Annals of Surgical Oncology. 14(12):3328–3334; Dilts, D. (2008). Personal correspondence; February 2, 2008.
Addressing Disparities
IOM: increasing clinical trial participation among minorities can impact health disparities
Addressing issues of diversity and representation
affects study results NIH, FDA mandates
9
© 2013 ENACCT Inc. All Rights Reserved
Participation in Cancer Research: A Call to Action
1. Total census of patients of patients treated is closely matched to the demographics of the clinic’s catchment area
2. CCTs selected for local implementation will more appropriately meet the needs of local patients
3. 100% of patients starting treatment will be effectively screened for CCT eligibility
4. 100% of eligible patients will be offered CCT participation
10
Quality Improvement Goals toIncrease Cancer Trials Accrual
© 2013 ENACCT Inc. All Rights Reserved
Quality Improvement Goals toIncrease Cancer Trials Accrual5. Normalization of CCTs through effective internal,
external communication6. All patients interested in participation will have
their information, knowledge and behavior needs met through the consent process
7. All enrolled patients will receive adequate support to ensure their compliance and retention throughout the CCT
11
© 2013 ENACCT Inc. All Rights Reserved
Consent Process: What we “know”12
Informed Consent Process
The purpose of the trial What will happen during
the trial The risks and potential benefits Their individual rights
Must Explain to Participants…
Components Affecting Consent
Optimal Consent Process
Limited English
Values
Ethnicity
Desire for info
Physical Stress
Culture
Emotional Stress
Comprehension
Learning Style
Health Literacy/Literacy
14
© 2013 ENACCT Inc. All Rights Reserved
Why it Matters
Overreliance on the consent form rather than the process Exclusive use of “Take it home” procedure to assess
understanding
Inadequate assessment of comprehension Difficulty addressing multitude of patient needs in
context of clinical trials
Most people who participate in research do not understand common medical and research terms
15
© 2013 ENACCT Inc. All Rights Reserved
Key Factors Around Optimal Consent Process Written and verbal communication using plain
wording, and delivered in the language of the patient
Clinical encounters that are patient-centered and meeting literacy, language and cultural needs of the patient
16
© 2013 ENACCT Inc. All Rights Reserved
Health Literacy and Limited English Proficiency: Their Impact on Cancer Clinical Trials
17
Definition of Health Literacy
“The degree to which individuals have the capacity to obtain, communicate, process, and understand basic health information and services needed to make appropriate health decisions.”
- Affordable Care Act
18
© 2013 ENACCT Inc. All Rights Reserved
What is Health Literacy?
Skills in: Reading Writing Basic Math Speech Comprehension
Capacity to: Obtain Process and Understand Basic
Health Information
Relies on cultural/conceptual knowledge
Literacy Health Literacy
19
© 2013 ENACCT Inc. All Rights Reserved
Percentage of US Adults in Each Health Literacy Category
20
© 2013 ENACCT Inc. All Rights Reserved
Percentage of adults in each health literacy level, by race/ethnicity, 2003
14 9 2441
13 259
22 19
3425
1823
28
53 58
41 31
5245 59
12 14 2 4 18 7 3
0%
20%
40%
60%
80%
100%
TotalWhiteBlack
Hispanic APIAI/A
NMultir
acial
ProficientIntermediateBasicBelow Basic
Prevalence & Disparities
Source: NAAL
21
© 2013 ENACCT Inc. All Rights Reserved
DVD: Health Literacy
AMA Health Literacy Kitwww.ama-assn.org
Weiss B et al. American Medical Association (March 2003)
© 2013 ENACCT Inc. All Rights Reserved
22
Health Literacy Equation: Consider Impact with Clinical Trials
Skills/Abilities x Difficulty/Complexity = Health Literacy
X =
Potential “Red Flags” for LowHealth Literacy Doesn’t ask questions Says he/she forgot glasses Incomplete forms Missed appointments
24
Weiss 2003, Katz et al 2007
© 2013 ENACCT Inc. All Rights Reserved
The Form Itself
Large fonts, short lines, lots of white space, bulleted lists, and chunked text with headings make documents easier to read
New NCI Template
25
Resource: The PRISM Readability Toolkit
An 81‐page handbook for researchers illustrating how to use plain language in consent forms and other study materials.
Background information on health literacy & readability, template language for consent forms, an extensive alternative word list, several before‐and‐after examples, and more!
Download a free PDF at www.tinyurl.com/prismtoolkit
PRISM Online Training: http://prism.grouphealthresearch.org
Who are Patients with Limited English Proficiency? Individuals who do not speak English as their
primary language and who have a limited ability to read, speak, write, or understand English
Over 8% of U.S. residents - 21 million people - do not speak English well
In 4.4 million households – 11.9 million people – no one speaks English very well
US Census
27
© 2013 ENACCT Inc. All Rights Reserved
Patients with LEP and Trials
Many are overlooked May have harder time reading and understanding
health-related information, even in own language IRBs provide little guidance regarding inclusion of
LEP patients in research Anticipate and prepare language access needs for LEP
patients BEFORE they walk through the door Appropriate translation of written materials AND use
of interpreter services are both KEY
OHRP approved “short form”
28
© 2013 ENACCT Inc. All Rights Reserved
Patients with LEP and Trials
HHS Guidance: OBTAINING AND DOCUMENTING INFORMED CONSENT OF SUBJECTS WHO DO NOT SPEAK ENGLISH
29
© 2013 ENACCT Inc. All Rights Reserved
Maintain focus on the patient and watch for cues of understanding/confusion
Must comply with confidentiality guidelines Family members should not serve as interpreter Even trained interpreters may not understand
nuances around trials NOTE: Research staff is still in charge of consenting
process; interpreter is merely the means of communicating with the patient
Patients with LEP and Trials-Working With Interpreters
Adapted from A Physician’s Practical Guide to Culturally Competent Care, available at https://www.thinkculturalhealth.hhs.gov/
© 2013 ENACCT Inc. All Rights Reserved
30
Use plain language Encourage interpreters and patients to interrupt
when they do not understand and make every possible attempt to simplify and clarify
Respect professional boundaries and abide by the code of ethics of interpreters
Recognize that sight translation requires a different order of skills
Working With Interpreters: Things to Remember
© 2013 ENACCT Inc. All Rights Reserved
31
Working With Interpreters: Things to Remember
Do a pre-session with the interpreter, directing them to interpret in the first person
Interpreter should be seated or standing next to the patient.
The provider should face the patient so that they have direct eye contact with each other
Ira SenGupta, CCHCP
© 2013 ENACCT Inc. All Rights Reserved
32
Ensuring Understanding During Consent (for everyone)
33
Worst Question to Ask to Check Understanding
Do You Understand?
Adapted from Health Literacy Introductory Kit (AMA, 2003)
34
© 2013 ENACCT Inc. All Rights Reserved
Tips to Enhance Understanding During the Consent Process Improve verbal communication
• Speak slowly and use clear, simple language• Use the “teach back” technique • Use the “chunks and checks” technique• Discuss specific behaviors (what the patient will do)
Complement and modify written language• Consider using pictures, flow charts, models, or other
graphics to supplement the spoken word • Use translated forms
Adapted from Health Literacy Introductory Kit (AMA, 2003)
35
© 2013 ENACCT Inc. All Rights Reserved
Tips to Enhance Understanding During the Consent Process (cont’d) Create a shame-free environment
• Look for clues of low literacy and react non-judgmentally
• Offer help with paperwork• Read materials aloud • Give permission to ask questions
Use available resources• Offer the opportunity for family and friends to be
with patients during discussions• Language line, interpreters
36
© 2013 ENACCT Inc. All Rights Reserved
Sample Scripts to Assess Comprehension I want to make sure I explained everything clearly. If
you were trying to explain what you’re doing in this study to a family member, what would you say?
Let’s review the main side effects...what are the two things I asked you to watch out for?
What questions do you have?
S. Titus et al., "Do you understand? An ethical assessment of researchers' description of the consenting process," J Clin Ethics 7 (1996): 60-8
37
© 2013 ENACCT Inc. All Rights Reserved
Sample Scripts to Assess Comprehension Tell me in your own words what this study is all about. Tell me what you think will happen to you in this study. What do you expect to gain by taking part in this
research? What risks might you experience by participating in
the research? What are your alternatives (other choices or options
to participating in this research)?S. Titus et al., "Do you understand? An ethical assessment of researchers' description of the consenting
process," J Clin Ethics 7 (1996): 60-8
38
© 2013 ENACCT Inc. All Rights Reserved
Patient-centered consent process39
What Is Patient-Centered Care?
“Providing care that is respectful of and responsive to individual patient preferences, needs, and value, ensuring that patient values guide all clinical decisions.” (Institute of Medicine. Crossing the Quality Chasm, 2001)
“Quality healthcare achieved through a partnership between informed and respected patients and their families and a coordinated healthcare team.” (National Health Council. http://www.nationalcouncil.org/initiatives/putting_patients.htm)
40
© 2013 ENACCT Inc. All Rights Reserved
Patient-Centered Factors Affecting Optimal Decision Making Emotional, Physical, Cognitive Overload +
decisional conflict
Ineffective Patient- Provider Communication Different cultures and values Different learning styles Low Health Literacy Limited English Proficiency
© 2013 ENACCT Inc. All Rights Reserved
41
What About Culture?
Culture is the customs, beliefs, values, knowledge, and skills that guide a people’s behavior along shared pathsLinton, R. The Study of Man. New York, NY: Appleton Press, 1947.
Not restricted to race or ethnicity!!
Linton R. The Study of Man (1947)
42
© 2013 ENACCT Inc. All Rights Reserved
What We See and What We Don’t 43
© 2013 ENACCT Inc. All Rights Reserved
We Are All Complex Cultural Beings!
Complex Cultural Being
Language Color
Values
Ethnicity
Race
Sexual Orientation
Class
Ability/disability
Age
Health
Education
Economic Realities
Profession/work
Spiritual Beliefs
Health Literacy
Ira SenGupta, CCHCP 2006
44
© 2013 ENACCT Inc. All Rights Reserved
Learning Styles and the Consent Process
Visual Learner
Auditory Learner
Sensory Learner
Kinesthetic Learner
Adapted from: Teachers Make The Difference by Susan Kovalik
We learn best when there is a match between our preferred learning style and how new information is presented
© 2013 ENACCT Inc. All Rights Reserved
45
Patient Centered Communication Around Tx Decision-Making Assess patients needs and preferences Acknowledge emotions involved in decision-making Speak in simple language
Need to know vs nice to know at this time
Use graphic illustrations to help communicate risk (for ex. 100-person diagram)
Use of decision aids (booklet, facts sheets, websites, etc.) to help patient consider care options
Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. 2001; Charles C Gafni A, Whelan T.. Soc Sci Med.. 1999; 49: 651-661.;Charles C Whelan T Gafni BMJ 1999; 319: 780-782; Fagerlin A wang C Ubel PA. Med Descis Making. 2005; 25: 398-405; Timmermans D, Molewijk B, Stiggelbout A, Kievit J. Patient Edu Couns. 2004; 54: 255-263; Fuller R, Dudley N, Blacktop J. Postgrad Med 2002; 78: 543-544;Fuller R , Dudley N, Blacktop J.. 2001; 30: 473-476.
46
© 2013 ENACCT Inc. All Rights Reserved
Fostering a Partnership
Core communication skills and strategies for shared decision-making: Declare the agenda Endorse question asking Explore patient’s values and lifestyle through open
ended questions, clarification and validation Present a clear statement and summary Close the consultation
47
© 2013 ENACCT Inc. All Rights Reserved
Fostering a Partnership
o Partners in a joint venueo Shared enterpriseo Invitation to participate (participant vs. subject)o Practices that emphasize communication and
continuity are associated with higher levels of trust in physicians
How is trust experienced in a clinical context?
48
© 2013 ENACCT Inc. All Rights Reserved
Challenging Concepts: Randomization Public’s and patients’ preferences for
descriptions of randomization compared with clinicians’ own practice
49
Jenkins V, Leach L, Fallowfield L et al British Journal of Cancer 2002 87(8) 854-858
© 2013 ENACCT Inc. All Rights Reserved
Explaining Concepts: Titering
Clinical Trial vs. Standard Treatment
Use of Placebo
Answering the “guinea pig” question
50
© 2013 ENACCT Inc. All Rights Reserved